Endocrinology, doi:10.1210/en.2004-1083
Endocrinology Vol. 146, No. 2 901-912
Copyright © 2005 by The Endocrine Society
1A-Adrenoceptors Activate Glucose Uptake in L6 Muscle Cells through a Phospholipase C-, Phosphatidylinositol-3 Kinase-, and Atypical Protein Kinase C-Dependent Pathway
Dana S. Hutchinson and
Tore Bengtsson
Department of Physiology, The Wenner-Gren Institute, Arrhenius Laboratories F3, Stockholm University, SE 10691 Stockholm, Sweden
Address all correspondence and requests for reprints to: Dr. Tore Bengtsson, Department of Physiology, The Wenner-Gren Institute, Arrhenius Laboratory F3, Stockholm University, SE 10691 Stockholm, Sweden. E-mail: tore.bengtsson{at}zoofys.su.se.
The role of
1-adrenoceptor activation on glucose uptake in L6 cells was investigated. The
1-adrenoceptor agonist phenylephrine [pEC50 (log10 EC50), 5.27 ± 0.30] or cirazoline (pEC50, 5.00 ± 0.23) increased glucose uptake in a concentration-dependent manner, as did insulin (pEC50, 7.16 ± 0.21). The
2-adrenoceptor agonist clonidine was without any stimulatory effect on glucose uptake. The stimulatory effect of cirazoline was inhibited by the
1-adrenoceptor antagonist prazosin, but not by the ß-adrenoceptor antagonist propranolol. RT-PCR showed that the
1A-adrenoceptor was the sole
1-adrenoceptor subtype expressed in L6 cells. Cirazoline- or insulin-mediated glucose uptake was inhibited by the phosphatidylinositol-3 kinase inhibitor LY294002, suggesting a possible interaction between the
1-adrenoceptor and insulin pathways. Cirazoline or insulin stimulated phosphatidylinositol-3 kinase activity, but
1-adrenoceptor activation did not phosphorylate Akt. Both cirazoline- and insulin-mediated glucose uptake were inhibited by protein kinase C (PKC), phospholipase C, and p38 kinase inhibitors, but not by Erk1/2 inhibitors (despite both treatments being able to phosphorylate Erk1/2). Insulin and cirazoline were able to activate and phosphorylate p38 kinase. The phorbol ester 12-O-tetradecanoylphorbol-13-acetate and the calcium ionophore A23187 produced significant increases in glucose uptake, indicating roles for PKC and calcium in glucose uptake. Down-regulation of conventional PKC isoforms inhibited glucose uptake mediated by 12-O-tetradecanoylphorbol-13-acetate, but not by insulin or cirazoline. This study demonstrates that
1-adrenoceptors mediate increases in glucose uptake in L6 muscle cells. This effect appears to be related to activation of phospholipase C, phosphatidylinositol-3 kinase, p38 kinase, and PKC.
This article has been cited by other articles:

|
 |

|
 |
 
B.-G. Tuo, G.-R. Wen, and U. Seidler
Phosphatidylinositol 3-kinase is involved in prostaglandin E2-mediated murine duodenal bicarbonate secretion
Am J Physiol Gastrointest Liver Physiol,
July 1, 2007;
293(1):
G279 - G287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Faenza, G. Ramazzotti, A. Bavelloni, R. Fiume, G. C. Gaboardi, M. Y. Follo, R. S. Gilmour, A. M. Martelli, K. Ravid, and L. Cocco
Inositide-Dependent Phospholipase C Signaling Mimics Insulin in Skeletal Muscle Differentiation by Affecting Specific Regions of the Cyclin D3 Promoter
Endocrinology,
March 1, 2007;
148(3):
1108 - 1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Z. Zeng, Y. Jia, N. J. Hahn, S. M. Markwart, K. F. Rockwood, and D. L. Livant
Role of Focal Adhesion Kinase and Phosphatidylinositol 3'-Kinase in Integrin Fibronectin Receptor-Mediated, Matrix Metalloproteinase-1-Dependent Invasion by Metastatic Prostate Cancer Cells
Cancer Res.,
August 15, 2006;
66(16):
8091 - 8099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tao, H. Maegawa, S. Ugi, K. Ikeda, Y. Nagai, K. Egawa, T. Nakamura, S. Tsukada, Y. Nishio, S. Maeda, et al.
The Transcription Factor AP-2{beta} Causes Cell Enlargement and Insulin Resistance in 3T3-L1 Adipocytes
Endocrinology,
April 1, 2006;
147(4):
1685 - 1696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Hutchinson and T. Bengtsson
AMP-Activated Protein Kinase Activation by Adrenoceptors in L6 Skeletal Muscle Cells: Mediation by {alpha}1-Adrenoceptors Causing Glucose Uptake
Diabetes,
March 1, 2006;
55(3):
682 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chernogubova, D. S. Hutchinson, J. Nedergaard, and T. Bengtsson
{alpha}1- and {beta}1-Adrenoceptor Signaling Fully Compensates for {beta}3-Adrenoceptor Deficiency in Brown Adipocyte Norepinephrine-Stimulated Glucose Uptake
Endocrinology,
May 1, 2005;
146(5):
2271 - 2284.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by The Endocrine Society